mRNA Victoria
Overview
mRNA Victoria is a Victorian Government agency responsible for building a leading mRNA and RNA industry in the Asia Pacific region through strategic investments, grants, and partnerships.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| RAGE Biotech | Jul 2022 | Grant | Co-investor |
| Zitra Medicines | Jul 2025 | Grant | Lead |
| Messenger Bio | Sep 2024 | Grant | Co-investor |
Key People
Alexandra Tran
Principal Solicitor, Legislation
Claire Levey
Principal Adviser Regional Development Victoria, Principal Adviser Office of the Secretary
Helen Garrity
Principal Solicitor
Jennifer Toom-Hicks
Principal Advisor to Deputy Secretary Corporate Service's
Lachlan Richards
Managing Principal Solicitor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is mRNA Victoria based?
mRNA Victoria is headquartered in Melbourne, Australia.
When was mRNA Victoria founded?
mRNA Victoria was founded in 2021.
How many portfolio companies does mRNA Victoria have?
mRNA Victoria has 3 portfolio companies in Caplight's dataset.
What are some companies in mRNA Victoria's portfolio?
Portfolio companies visible on Caplight include RAGE Biotech, Zitra Medicines, Messenger Bio.
What was mRNA Victoria's most recent investment shown here?
mRNA Victoria's most recent investment in this portfolio sample was in Zitra Medicines in 2025.
What sectors does mRNA Victoria focus on?
mRNA Victoria focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does mRNA Victoria focus on?
Stage focus information for mRNA Victoria is not publicly available.
What is mRNA Victoria's AUM?
mRNA Victoria's assets under management are estimated between $33.0M and $33.0M.